Alexion Pharmaceuticals (ALXN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/29/20
Alexion Pharmaceuticals to Initiate Phase 3 Study for Ultomiris as a Potential Coronavirus TreatmentThe Motley Fool • 04/20/20
3 Value Stocks to Buy With Your $1,200 Stimulus Check That Can Make You RichThe Motley Fool • 04/11/20
Alexion Pharmaceuticals (ALXN) Gains But Lags Market: What You Should KnowZacks Investment Research • 03/26/20
Alexion (ALXN) Down 6.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 02/29/20
Alexion Pharmaceuticals: Pipeline Diversification Outweighs The Patent UncertaintySeeking Alpha • 02/17/20